Please Wait

Applying Filters...

Ceftazidim
CEP/COS
Table View

Antibiotic market to reach US$ 74.07 billion by 2033; FDA approves GSK’s Blujepa for uncomplicated UTIs

Data Compilation
#PharmaFlow

Pipeline Prospector November 2025: Kimberly-Clark to buy Kenvue for US$ 48.7 bn; FDA approves Novartis’ gene therapy

Stock Recap
#PipelineProspector

Ceftazidim

ACCESS ALL DATA, CHEMISTRY

ACTIVE PHARMA INGREDIENTS

42 API Suppliers, 18 USDMF, 16 CEP/COS, 6 JDMF, 3 EU WC, 4 KDMF, 4 NDC API, 17 Listed Suppliers, $ API Reference Price

DEVELOPMENTS

25 Drugs in Development

25 Drugs in Development

INTERMEDIATES

8 Intermediate Suppliers

8 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

313 FDF Dossiers, 42 FDA Orange Book, 172 Europe, 6 Canada, 16 South Africa, 77 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

POWDER;INTRAVENOUS - EQ 0.5GM BASE;2GM/VIAL, INJECTABLE;INJECTION - 1GM/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, INJECTABLE;INJECTION - 2GM/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, INJECTABLE;INJECTION - 500MG/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, INJECTABLE;INJECTION - 6GM/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, INJECTABLE;INJECTION - EQ 20MG BASE/ML, INJECTABLE;INJECTION - EQ 40MG BASE/ML, INJECTABLE;INJECTION - EQ 1GM BASE, INJECTABLE;INJECTION - EQ 2GM BASE

RELATED EXCIPIENT COMPANIES

1 Kirsch Pharma, 1 Actylis, 1 Kerry, 1 Microlex e.U, 1 Pluviaendo, 1 Roquette

EXCIPIENTS BY APPLICATIONS

3 Parenteral, 2 Fillers, Diluents & Binders, 1 Taste Masking, 1 Chewable & Orodispersible Aids

DIGITAL CONTENT

25 News #PharmaBuzz

25 News #PharmaBuzz

GLOBAL SALES INFORMATION

5 US Medicaid Prescriptions, 76 Regulatory FDF Prices, 9 Annual Reports

MARKET PLACE

23 APIs, 20 FDF Dossiers

PATENTS & EXCLUSIVITIES

10 US Patents, 4 US Exclusivities

REF. STANDARDS & IMPURITIES

2 EDQM, 6 Others

$ Xls download

Filters

Log in to download the data

Last Updated on PharmaCompass	Virtual Booth	Country	Certificate Holder	Certificate No.	Substance	Issue Date	Status	Type	End Date	Substance No.
29/11/2025	ACS DOBFAR SPA	Italy	ACS DOBFAR S.P.A. Tribiano IT	CEP 2023-299 - Rev 00	Ceftazidime Pentahydrate, Sterile	2024-07-29	Valid	Chemical		1405
29/11/2025	Antibioticos do Brasil Ltda	Brazil	ANTIBIOTICOS DO BRASIL LTDA. Cosmopolis BR	CEP 2010-026 - Rev 03	Ceftazidime pentahydrate with sodium carbonate for injection, Sterile	2024-04-15	Valid	Chemical		2344

Contact us
to update this info

Ceftazidim

Ceftazidim

ACCESS ALL DATA

Browse all information

CHEMISTRY

Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

42 API Suppliers

18 USDMF

16 CEP/COS

6 JDMF

3 EU WC

4 KDMF

4 NDC API

17 Listed Suppliers

$ API Reference Price

DEVELOPMENTS

25 Drugs in Development

INTERMEDIATES

8 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

313 FDF Dossiers

42 FDA Orange Book

172 Europe

6 Canada

16 South Africa

77 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

POWDER;INTRAVENOUS - EQ 0.5GM BASE;2GM/VIAL

INJECTABLE;INJECTION - 1GM/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

INJECTABLE;INJECTION - 2GM/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

INJECTABLE;INJECTION - 500MG/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

INJECTABLE;INJECTION - 6GM/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

INJECTABLE;INJECTION - EQ 20MG BASE/ML

INJECTABLE;INJECTION - EQ 40MG BASE/ML

INJECTABLE;INJECTION - EQ 1GM BASE

INJECTABLE;INJECTION - EQ 2GM BASE

RELATED EXCIPIENT COMPANIES

1 Kirsch Pharma

1 Actylis

1 Kerry

1 Microlex e.U

1 Pluviaendo

1 Roquette

EXCIPIENTS BY APPLICATIONS

3 Parenteral

2 Fillers, Diluents & Binders

1 Taste Masking

1 Chewable & Orodispersible Aids

DIGITAL CONTENT

25 News #PharmaBuzz

GLOBAL SALES INFORMATION

5 US Medicaid Prescriptions

76 Regulatory FDF Prices

9 Annual Reports

MARKET PLACE

23 APIs

20 FDF Dossiers

PATENTS & EXCLUSIVITIES

10 US Patents

4 US Exclusivities

REF. STANDARDS & IMPURITIES

2 EDQM

6 Others

Filters

INJECTABLE;INJECTION - 1GM/VIAL Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

INJECTABLE;INJECTION - 2GM/VIAL Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

INJECTABLE;INJECTION - 500MG/VIAL Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

INJECTABLE;INJECTION - 6GM/VIAL Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons